首页>
外国专利>
New pharmaceutical composition, useful for preventing or treating viral or bacterial infections caused by a pathogen selected from HIV-1 virus, Ebola virus, hepatitis C virus, Mycobacterium tuberculosis and Helicobacter pylori
New pharmaceutical composition, useful for preventing or treating viral or bacterial infections caused by a pathogen selected from HIV-1 virus, Ebola virus, hepatitis C virus, Mycobacterium tuberculosis and Helicobacter pylori
A pharmaceutical composition comprising polypeptide comprising any of fully defined 135 amino acids (SEQ ID NO1-3) given in the specification, is new. An independent claim is a complementary DNA (cDNA) encoding for polypeptide comprising any of SEQ ID NO. 1-3. ACTIVITY : Virucide; Antibacterial; Anti-HIV; Antiinflammatory; Hepatotropic; Antitubercular; Tuberculostatic. No biological data given. MECHANISM OF ACTION : None given.
展开▼
机译:包含多肽的药物组合物是新的,该多肽包含说明书中给出的完全定义的135个氨基酸(SEQ ID NO1-3)中的任何一个。独立的权利要求是编码包含SEQ ID NO.1的多肽的互补DNA(cDNA)。 1-3。活动:杀病毒剂;抗菌;抗艾滋病毒;消炎(药;肝抗结核结核病。没有给出生物学数据。作用机理:未给出。
展开▼